Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

REP. BLILEY REITERATES INTEREST IN "FUNDAMENTAL" REFORM FOR FDA; COMMERCE COMMITTEE CHAIRMAN VOWS TO HOLD HEARINGS, MOVE BILL IN EARLY 1996

This article was originally published in The Gray Sheet

Executive Summary

FDA cannot be left to its own devices when it comes to reform efforts, House Commerce Committee Chairman Thomas Bliley (R-Va.) asserted in calling for "fundamental" FDA reform legislation at the 39th annual Food and Drug Law Institute Educational Conference Dec. 12 in Washington, D.C.
UsernamePublicRestriction

Register

MT005216

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel